Segment adjusted EBITDAs of $107m in Q2 2025 (+14% year-on-year) or 39% margin (c.+270 bps). Profitability increase mostly driven by: 1/ the end of vessel penalties at EDA in January 2025 and 2/ good ...

Freddie Mac posted net income of $2.4 billion in Q2 2025, down 14% year over year, driven primarily by an increase in credit ...

Q2 2025 Management View Martina L. Cheung, President and CEO, highlighted strong second-quarter performance, with revenue ...

AbbVie's beat Wall Street's estimates for its top- and bottom-lines in the second quarter, boosted by sales of Skyrizi and Rinvoq. S&P Global said second-quarter profit rose due to "resilience in the ...

We have continued to invest in growth, while we maintained a strong cost discipline. Euronext reached an adjusted EBITDA ...

As Meta Platforms shifts focus and rides a bullish trend, investors should formulate a strategy for all likely outcomes. 24/7 ...

CVS Health topped Wall Street expectations for the second quarter and it's hiking its full-year forecast again, as the health ...

Q2 2025 Management View David A. Zapico, CEO, announced "AMETEK delivered strong second quarter results, highlighted by ...

Bombardier delivered an upbeat second quarter report July 31, buoyed by a large fleet order from an unnamed customer and the ...

Things got a bit testy during the third quarter of Wednesday night's Atlanta Dream vs. Dallas Wings game, when Dream center Brittney Griner had to be held back from a referee and was eventually ...

The company reported second-quarter GAAP earnings per share of $1.28 on revenue that soared 42% to a quarterly record of $4.84 billion. Analysts surveyed by Visible Alpha had expected $0.97 and $4.58 ...

As for its neuroscience portfolio, AbbVie has added $300 million, putting its projection for the year at $10.5 billion, which ...